المؤلفون: Tess Montada-Atin, G. V. Ramesh Prasad

المصدر: World Journal of Diabetes

مصطلحات موضوعية: medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Population, 030209 endocrinology & metabolism, Review, Type 2 diabetes, Disease, 030204 cardiovascular system & hematology, Glucagon-like peptide-1 receptor agonists, Kidney transplantation, 03 medical and health sciences, 0302 clinical medicine, Dipeptidyl peptidase-4 inhibitors, Internal medicine, Diabetes mellitus, Internal Medicine, medicine, Post-transplant diabetes mellitus, education, education.field_of_study, business.industry, Oral antihyperglycemic drugs, Acute kidney injury, Cardiovascular disease, medicine.disease, Transplantation, Heart failure, business, Sodium glucose co-transporter 2 inhibitors

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6111ba72f2e18ba5c1fe30c56de1c10Test
https://doi.org/10.4239/wjd.v12.i5.541Test

المؤلفون: Jaime Blais, Michael Durkin

المصدر: Diabetes Therapy

مصطلحات موضوعية: medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, Urology, Renal function, 030209 endocrinology & metabolism, 030204 cardiovascular system & hematology, Placebo, Diabetic nephropathy, 03 medical and health sciences, 0302 clinical medicine, Diabetes mellitus, Type 2, Diabetes mellitus, Internal Medicine, Medicine, Renal insufficiency, chronic, Canagliflozin, Kidney transplantation, Dialysis, Original Research, business.industry, medicine.disease, Cost of illness, business, Sodium glucose co-transporter 2 inhibitors, Kidney disease, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c86c07014dd86bc3613ad7875343bccTest
https://doi.org/10.1007/s13300-020-00953-4Test

المؤلفون: Fumitaka Okajima, Susumu Nakamura, Yoshiro Maezawa, Ryoichi Ishibashi, Yusuke Baba, Chihiro Hiraga, Daigaku Uchida, Tomomi Harama, Tetsuya Yamamoto, Atsushi Takasaki, Kyoka Kakinuma, Masaya Koshizaka

المصدر: Diabetes Therapy

مصطلحات موضوعية: medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, medicine.medical_treatment, 030209 endocrinology & metabolism, 030204 cardiovascular system & hematology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Patient satisfaction, Diabetes mellitus, Internal medicine, Internal Medicine, medicine, Prospective cohort study, Sodium glucose co-transporter 2 inhibitor, Glycemic, Type 1 diabetes, business.industry, Brief Report, Insulin, medicine.disease, Ipragliflozin, chemistry, Type 1 DM, Glycated hemoglobin, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41e77cac68ef930131696d8de07345b1Test
https://doi.org/10.1007/s13300-020-00971-2Test

المؤلفون: Giorgio Zanette, Paola Ponzani, Gaetano Serviddio, Giuseppe Memoli, Roberto Anichini, Patrizio Pasqualetti, Salvatore Caputo, Giulio Marchesini, Manfredi Rizzo, Veronica Resi

المساهمون: Marchesini G., Pasqualetti P., Anichini R., Caputo S., Memoli G., Ponzani P., Resi V., Rizzo M., Serviddio G., Zanette G.

المصدر: Acta Diabetologica. 56:289-299

مصطلحات موضوعية: Drug Administration Route, Endocrinology, Diabetes and Metabolism, Urogenital-tract infection, Type 2 diabetes, 030204 cardiovascular system & hematology, Logistic regression, choice behavior, 0302 clinical medicine, Endocrinology, Weight loss, italy, middle aged, Surveys and Questionnaire, urogenital-tract infections, humans, injectable drugs, glucagon-like peptide-1 receptor agonists, glucagon-like peptide-1 receptor, Sodium–glucose co-transporter 2 inhibitor, drug, dosage forms, General Medicine, dose frequency, nausea, Random effects model, aged, female, type 2, diabetes mellitus, Glucagon-like peptide-1 receptor agonist, medicine.symptom, Human, Adverse event, medicine.medical_specialty, Nausea, adverse events, oral treatment, route of delivery, sodium–glucose co-transporter 2 inhibitors, weight loss, body veight, diabetes mellitus, type 2, dose-response relationship, drug, drug administration routes, drug administration schedule, hypoglycemic agents, male, patient preference, surveys and questionnaires, Injectable drug, 030209 endocrinology & metabolism, Weight lo, dose-response relationship, 03 medical and health sciences, Route of administration, Internal medicine, Internal Medicine, medicine, Dosing, Adverse effect, Hypoglycemic Agent, Dose-Response Relationship, Drug, business.industry, Settore MED/09 - MEDICINA INTERNA, Body Weight, medicine.disease, Diabetes Mellitus, Type 2, business

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcf28579ec7253a45644098848c7ffb2Test
https://doi.org/10.1007/s00592-018-1236-6Test

المؤلفون: Iskandar Idris, Sophie A. Millar, Afnan S. Alshnbari, Saoirse E. O'Sullivan

المصدر: Diabetes Therapy

مصطلحات موضوعية: Sodium-glucose co-transporter 2 inhibitors, Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, Review, 030204 cardiovascular system & hematology, Pharmacology, Endothelial, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, In vivo, Vascular, Internal Medicine, Empagliflozin, medicine, Dapagliflozin, Endothelial dysfunction, Canagliflozin, business.industry, medicine.disease, Ipragliflozin, chemistry, Systematic review, business, Tofogliflozin, Ex vivo, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3eaa1b841df27ce1da6a34169a69b840Test
https://doi.org/10.1007/s13300-020-00885-zTest

المؤلفون: Zhenmei An, Lin Zhang, Lidan Yang, Mei Zhang, He He

المصدر: Diabetes Therapy

مصطلحات موضوعية: Sodium-glucose co-transporter 2 inhibitors, medicine.medical_specialty, East Asians, Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Cochrane Library, law.invention, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, Diabetes mellitus, Internal medicine, Type 2 diabetes mellitus, Internal Medicine, medicine, Original Research, business.industry, medicine.disease, Confidence interval, chemistry, Relative risk, Meta-analysis, Glycated hemoglobin, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f585ef7f1baacb0a828ab299c0bd490Test
https://doi.org/10.1007/s13300-019-0674-7Test

المؤلفون: Eijiro Yamada, Yasuyo Nakajima, Aya Osaki, Junichi Okada, Tsugumichi Saito, Yawara Niijima, Atsushi Ozawa, Masanobu Yamada, Yoko Shimoda, Shuichi Okada

المصدر: Diabetes Therapy

مصطلحات موضوعية: Glycosuria, medicine.medical_specialty, endocrine system diseases, Endocrinology, Diabetes and Metabolism, Type 1 diabetes mellitus, 030209 endocrinology & metabolism, 030204 cardiovascular system & hematology, Renal threshold for glucose reabsorption, Sodium-glucose co-transporter 2 inhibitor, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Diabetes mellitus, Internal medicine, Type 2 diabetes mellitus, Internal Medicine, medicine, Type 1 diabetes, business.industry, Brief Report, nutritional and metabolic diseases, Type 2 Diabetes Mellitus, medicine.disease, Renal glucose reabsorption, Endocrinology, Ipragliflozin, chemistry, Renal threshold, medicine.symptom, SGLT2 Inhibitor, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c75884ce95d7cd1ec92205a3e41254fcTest
https://doi.org/10.1007/s13300-019-0649-8Test

المؤلفون: Noboru Kurinami, Seigo Sugiyama, Tomio Jinnouchi, Katsunori Jinnouchi, Akira Yoshida, Kunio Hieshima, Fumio Miyamoto, Tomoko Suzuki, Motoko Tanaka, Hideaki Jinnouchi, Keizo Kajiwara

المصدر: Journal of Clinical Medicine Research

مصطلحات موضوعية: Sodium-glucose co-transporter 2 inhibitors, medicine.medical_specialty, Urinary system, Urology, Renal function, 030209 endocrinology & metabolism, 030204 cardiovascular system & hematology, Kidney, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Diabetes mellitus, Type 2 diabetes mellitus, medicine, Estimated glomerular filtration rate, Annual eGFR decline, Rapid eGFR decliner, Urine protein-to-creatinine ratio, Creatinine, business.industry, Type 2 Diabetes Mellitus, Renoprotection, General Medicine, medicine.disease, medicine.anatomical_structure, chemistry, Original Article, SGLT2 Inhibitor, business, Kidney disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9548e6321e490ea0895c4c62e150d14Test
https://doi.org/10.14740/jocmr3761Test

المؤلفون: Jessica W. Skelley, Megan Z. Roberts, Brooke S Carter

المصدر: Vascular Health and Risk Management

مصطلحات موضوعية: Male, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, sodium-glucose co-transporter 2 inhibitors, 030209 endocrinology & metabolism, Review, Type 2 diabetes, Disease, 030204 cardiovascular system & hematology, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, cardiovascular disease, Diabetes mellitus, Internal medicine, medicine, Humans, Pharmacology (medical), Canagliflozin, Adverse effect, Sodium-Glucose Transporter 2 Inhibitors, Aged, business.industry, Public Health, Environmental and Occupational Health, Type 2 Diabetes Mellitus, Hematology, General Medicine, Middle Aged, Protective Factors, medicine.disease, Treatment Outcome, Blood pressure, Diabetes Mellitus, Type 2, Cardiovascular Diseases, antihyperglycemic, diabetes mellitus, Female, Cardiology and Cardiovascular Medicine, business, medicine.drug, Kidney disease

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce99a51ac4ce1ac82eb79db904575cacTest
https://doi.org/10.2147/vhrm.s168472Test

المؤلفون: García-Carro, Clara, Vergara, Ander, Agraz Pamplona, Irene, Jacobs-Cachá, Conxita, Espinel, Eugenia, Seron, Daniel, Soler, María José, Universitat Autònoma de Barcelona

المساهمون: Institut Català de la Salut, [García-Carro C, Vergara A] Grup de Recerca en Nefrologia, Vall d’Hebron Institut de Recerca, Barcelona, Spain. Servei de Nefrologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Agraz I, Jacobs-Cachá C, Espinel E, Seron D, Soler MJ] Grup de Recerca en Nefrologia, Vall d’Hebron Institut de Recerca, Barcelona, Spain. Servei de Nefrologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. Red de Investigación Renal (REDINREN), Instituto Carlos III, Madrid, Spain., Vall d'Hebron Barcelona Hospital Campus

المصدر: Journal of Clinical Medicine
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Journal of Clinical Medicine, Vol 8, Iss 6, p 864 (2019)
Scientia

مصطلحات موضوعية: Nefropaties diabètiques - Fisiologia patològica, Sodium-glucose co-transporter 2 inhibitors, Otros calificadores::/fisiología [Otros calificadores], Other subheadings::/physiology [Other subheadings], lcsh:Medicine, 030209 endocrinology & metabolism, sodium-glucose co-transporter 2 inhibitors, Type 2 diabetes, Disease, Review, dipeptidyl peptidase 4 inhibitors, 030204 cardiovascular system & hematology, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Bioinformatics, acciones y usos químicos::acciones farmacológicas::acciones y usos químicos::acciones farmacológicas::efectos fisiológicos de los fármacos::hipoglicemiantes::inhibidores de la dipeptidil-peptidasa IV [COMPUESTOS QUÍMICOS Y DROGAS], Glucagon-like peptide-1 receptor agonists, Endocrine System Diseases::Diabetes Mellitus::Diabetes Complications::Diabetic Nephropathies [DISEASES], Chemical Actions and Uses::Pharmacologic Actions::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Hypoglycemic Agents::Dipeptidyl-Peptidase IV Inhibitors [CHEMICALS AND DRUGS], 03 medical and health sciences, 0302 clinical medicine, reno-cardiovascular protection, Diabetes management, Diabetes mellitus, medicine, Nefropaties diabètiques - Tractament, Other subheadings::/therapeutic use [Other subheadings], Diabetic kidney disease, Reno-cardiovascular protection, Dipeptidyl peptidase-4, Otros calificadores::Otros calificadores::/tratamiento farmacológico [Otros calificadores], glucagon-like peptide-1 receptor agonists, diabetes, Otros calificadores::/uso terapéutico [Otros calificadores], business.industry, lcsh:R, Diabetes, General Medicine, medicine.disease, Antidiabètics - Ús terapèutic, diabetic kidney disease, enfermedades del sistema endocrino::diabetes mellitus::complicaciones de la diabetes::nefropatías diabéticas [ENFERMEDADES], Dipeptidyl peptidase 4 inhibitors, Heart failure, Albuminuria, medicine.symptom, business, Kidney disease

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::858333aa069a6cc2c000519864e3a259Test
https://pubmed.ncbi.nlm.nih.gov/31212945Test